Thymoquinone Mediates Müller Cell Apoptosis via miR-29b/SP1 Pathway: A Potential Therapeutic Approach in Diabetic Retinopathy
Drug Research · 01.02.2025 · 75 (02) · 76-83
DOI: 10.1055/a-2507-5528 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Research, erschienen am 01.02.2025. Verfasst von Khalid M Alkharfy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: MicroRNAs, Benzoquinones, Apoptosis, Diabetic Retinopathy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
This study aims to explore the therapeutic potential of thymoquinone (TQ) in DR by assessing its effects on Müller cell apoptosis through modulation of the miR-29b/SP1 pathway in a diabetic animal model. Healthy C57BL/6 mice (25 g) were used in the study. Retinal samples were collected from both normal and diabetic mice subjected to various treatments: TQ (1 mg/kg/day), glibenclamide (GLB, 250 mg/kg/day), sitagliptin (STG, 10 mg/kg/day), and metformin (MET, 5 mg/kg/day) over a period of 28 days. The study measured miR-29b and SP1 mRNA levels using qRT-PCR. Protein expressions of SP1, Bax, and bcl-2 were analyzed through western blotting, while Caspase-3 activity using an ELISA assay kit, and apoptosis levels by annexin V. TQ administration resulted in a 52% reduction in blood glucose levels. Similarly, GLB, STG, and MET treatments reduced blood glucose by 60%, 57%, and 61%, respectively (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
- Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
- Department of Physiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Zitieren
APA
Alkharfy, K. M., Ahmad, A., Raish, M., & Alenazy, M. F. (2025). Thymoquinone Mediates Müller Cell Apoptosis via miR-29b/SP1 Pathway: A Potential Therapeutic Approach in Diabetic Retinopathy. Drug Research, 75(02), 76-83. https://doi.org/10.1055/a-2507-5528
Vancouver
Alkharfy KM, Ahmad A, Raish M, Alenazy MF. Thymoquinone Mediates Müller Cell Apoptosis via miR-29b/SP1 Pathway: A Potential Therapeutic Approach in Diabetic Retinopathy. Drug Research. 2025;75(02):76-83. doi:10.1055/a-2507-5528
BibTeX
@article{Alkharfy2025,
author = {Alkharfy, Khalid M and Ahmad, Ajaz and Raish, Mohammad and Alenazy, Maha F},
title = {Thymoquinone Mediates Müller Cell Apoptosis via miR-29b/SP1 Pathway: A Potential Therapeutic Approach in Diabetic Retinopathy},
journal = {Drug Research},
year = {2025},
volume = {75},
number = {02},
pages = {76--83},
doi = {10.1055/a-2507-5528}
}
EUVIMED